HIF1A and myelodysplastic syndrome: We could assume that HIF-1α signaling inhibition may also have different effects on cultured CD34+ cells from MDS patients with <5% and >5% bone marrow blasts through mechanisms that have not been investigated in the present study but definitely need further elucidation.